IRIS UniCatt

Barone, Carlo Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.291
NA - Nord America 3.008
AS - Asia 2.083
SA - Sud America 409
AF - Africa 75
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.878
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.925
DE - Germania 1.475
SG - Singapore 956
CN - Cina 585
SE - Svezia 428
BR - Brasile 338
IT - Italia 265
PL - Polonia 235
UA - Ucraina 182
GB - Regno Unito 173
FR - Francia 125
VN - Vietnam 119
IE - Irlanda 106
IN - India 106
FI - Finlandia 71
ID - Indonesia 70
RU - Federazione Russa 69
TR - Turchia 44
CA - Canada 41
JP - Giappone 37
BE - Belgio 33
HK - Hong Kong 33
AR - Argentina 30
MX - Messico 30
NL - Olanda 28
ZA - Sudafrica 27
BD - Bangladesh 26
CI - Costa d'Avorio 22
ES - Italia 22
IR - Iran 21
IQ - Iraq 18
EC - Ecuador 16
AT - Austria 14
LT - Lituania 14
KR - Corea 13
RO - Romania 12
MA - Marocco 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 6
AU - Australia 6
CZ - Repubblica Ceca 6
RS - Serbia 6
SA - Arabia Saudita 6
VE - Venezuela 6
CL - Cile 5
CO - Colombia 5
JO - Giordania 5
UZ - Uzbekistan 5
CH - Svizzera 4
KE - Kenya 4
PE - Perù 4
PT - Portogallo 4
SN - Senegal 4
BG - Bulgaria 3
EU - Europa 3
GE - Georgia 3
MD - Moldavia 3
PS - Palestinian Territory 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
BY - Bielorussia 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
ML - Mali 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
LC - Santa Lucia 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 8.876
Salva come PNG Salva come JPEG
Città #
Singapore 478
Chandler 476
Ashburn 273
Warsaw 215
Ann Arbor 123
Jacksonville 114
Beijing 106
Dublin 104
San Mateo 97
Nürnberg 89
Nanjing 85
Wilmington 85
Cattolica 82
New York 80
Los Angeles 77
Jakarta 61
Boston 58
Chicago 54
Dearborn 54
Dallas 50
Munich 46
Houston 45
Fairfield 42
Moscow 40
Woodbridge 40
Ho Chi Minh City 37
Nanchang 36
Lawrence 34
Rome 34
Brussels 33
Frankfurt am Main 33
Hangzhou 33
Redmond 33
Hong Kong 31
Redwood City 31
Tokyo 30
São Paulo 29
Milan 28
Seattle 28
Izmir 27
Marseille 27
Hefei 26
Princeton 25
Hanoi 24
Shanghai 24
Abidjan 22
Boardman 21
Falls Church 20
Mountain View 20
Santa Clara 19
Helsinki 18
London 18
Cambridge 17
Hebei 17
San Francisco 17
Buffalo 16
Guangzhou 16
Johannesburg 16
Brooklyn 15
Can Tho 15
Orem 15
Shenyang 15
Bremen 14
Hyderabad 14
Leawood 14
Changsha 13
Kraków 13
Norwalk 13
Denver 12
Fremont 11
Kent 11
Kunming 11
Montreal 11
Phoenix 11
Poplar 11
The Dalles 11
Augusta 10
Lancaster 10
Rio de Janeiro 10
University Park 10
Amsterdam 9
Atlanta 9
Chennai 9
Detroit 9
Toronto 9
Ankara 8
Belo Horizonte 8
Erbil 8
Jiaxing 8
Manchester 8
Querétaro 8
Simi Valley 8
Zhengzhou 8
Andover 7
Guarulhos 7
Jinan 7
Kish 7
Mexico City 7
Mumbai 7
Nuremberg 7
Totale 4.242
Salva come PNG Salva come JPEG
Nome #
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival 391
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy 331
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 293
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 281
KRAS Early Testing: Consensus Iniziative and Cost-Effectiveness Evaluation for metastatic colerectal patiens in an Italian Setting 247
A phase II study of sunitinib in advanced hepatocellular carcinoma 244
Diagnosis and management of breast lymphoma: A single-institution retrospective analysis 241
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 216
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 211
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 205
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 180
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 173
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 169
Treatment options of simple bone cysts: the role of bone substitutes, growth factors and literature review 166
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 162
Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer 156
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 155
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 147
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 141
Are TKIs favourable for the elderly with non-small-cell lung cancer? 141
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 140
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 140
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 139
AMAROS Study: Overall Survival in Breast Cancer Subtypes 137
Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: a systematic review of published studies 135
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 129
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 128
The immune response to tumors as a tool toward immunotherapy 126
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial 125
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies 123
Advanced colon cancer: staging and prognosis by CEA test 122
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 121
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 117
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 115
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 115
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 111
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 110
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): A randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX 109
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 109
Gas in portal circulation and pneumatosis cystoides intestinalis during chemotherapy for advanced rectal cancer 107
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 105
Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: A change of paradigm in a case series 103
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 103
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 102
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 101
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 101
Indications for prophylactic osteosynthesis associated with curettage in benign and low-grade malignant primitive bone tumors of the distal femur in adult patients: a case series 94
LUX-Lung 7: is there enough data for a final conclusion? 91
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 90
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 89
Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score 88
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 84
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis 79
Randomised, placebo-controlled, double-blind, parallele-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer 78
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 78
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse 70
Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II study 69
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 69
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 67
The interference between oxaliplatin & anti-EGFR therapies: A different hypothesis to explain the 'unexplainable' 66
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC 61
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial 58
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 58
Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations 57
Multidisciplinary approach for HCC patients: hepatology for the oncologists 56
Soft tissue metastases in lung cancer: a review of the literature 54
New life for retrospective study in the precision oncology era 54
Targeted therapy in advanced gastric carcinoma: The future is beginning 53
Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line 35
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report 30
Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy 27
Totale 8.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.052
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021306 0 0 0 0 0 33 69 14 76 28 69 17
2021/2022704 54 44 19 79 49 29 16 108 37 49 80 140
2022/20231.267 182 179 106 226 54 158 64 103 118 25 41 11
2023/2024542 24 162 21 18 15 82 33 42 5 15 51 74
2024/20251.099 25 52 90 53 95 44 47 50 128 111 188 216
2025/20262.008 495 87 200 462 670 94 0 0 0 0 0 0
Totale 8.978